Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFIRI vs 5-FU/FA after liver metastasis resection
NCT00143403Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2001
- Primary completion
- Feb 2008
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in colorectal cancer (CRC), sponsored by Pfizer. Started Dec 2001; status: completed.
02
Drugs
irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00143403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143403.